Pharmaceutical: Actos, Pioglitazone HCl
Object Details
- Takeda Chemical Industries, LTD.
- Eli Lilly and Company
- Takeda Pharmaceuticals America, Inc.
- Description
- The indications or uses for this product are:
- Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. ACTOS should be taken once daily and can be taken without regard to meals.
- Location
- Currently not on view
- ca 2000
- ID Number
- 2004.3030.03
- catalog number
- 2004.3030.03
- nonaccession number
- 2004.3030
- Object Name
- pharmaceutical
- Physical Description
- pioglitazone HCl, 15 mg (drug active ingredients)
- Measurements
- box: 2 1/8 in x 3 5/8 in x 1 5/8 in; 5.3975 cm x 9.2075 cm x 4.1275 cm
- box: 2 3/8 in x 1 3/8 in x 1 3/8 in; 6.0325 cm x 3.4925 cm x 3.4925 cm
- place made
- Japan: Ōsaka, Ōsaka
- United States: Indiana, Indianapolis
- See more items in
- Medicine and Science: Medicine
- Health & Medicine
- Diabetes
- National Museum of American History
- Record ID
- nmah_1427150
- Metadata Usage (text)
- CC0
- GUID (Link to Original Record)
- https://n2t.net/ark:/65665/ng49ca746ad-a4df-704b-e053-15f76fa0b4fa
Related Content
There are restrictions for re-using this image. For more information, visit the Smithsonian's Terms of Use page .
International media Interoperability Framework
IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more.